The Supreme Court has rejected a request to review a $70 million Risperdal ruling against Johnson & Johnson over male breast growth side effects, meaning the verdict will stand.…
A new study finds that FDA warnings reduced the use of antipsychotics as chemical restraints on elderly nursing home residents, but in many cases, the facilities may have switched to other drugs which caused different health problems.…
A Pennsylvania judge upheld a massive Risperdal verdict, but reduced the original punitive damages from $8 billion to $6.8 million.…
A new study indicates psychotropic drugs cause genetic changes which leads to weight gain.…
A new study warns that only about 1-in-100 serious adverse drug events are reported to the FDA.…
Johnson & Johnson faces more than 100,000 lawsuits over problems with its products, which may cost up to $50 billion to settle.…
A Philadelphia jury has ordered Johnson & Johnson to pay $8 billion in punitive damages to a man who developed breasts as a child due to the side effects of Risperdal.…
A new study warns that giving dementia patients trazodone could be as risky as giving them atypical antipsychotics.…
Federal investigators report that a third of foster care children in the U.S. prescribed psychotropic drugs are given no treatment plan or medical monitoring while taking the powerful medications.…
A federal judge cleared the way for a class action lawsuit against Missouri officials, who plaintiffs say allowed unmonitored and uncontrolled prescribing of psychotropic drugs to foster children.…
